vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and TOOTSIE ROLL INDUSTRIES INC (TR). Click either name above to swap in a different company.

TOOTSIE ROLL INDUSTRIES INC is the larger business by last-quarter revenue ($196.3M vs $121.8M, roughly 1.6× Core Laboratories Inc.). TOOTSIE ROLL INDUSTRIES INC runs the higher net margin — 14.7% vs 4.2%, a 10.5% gap on every dollar of revenue. On growth, TOOTSIE ROLL INDUSTRIES INC posted the faster year-over-year revenue change (1.5% vs -1.4%). TOOTSIE ROLL INDUSTRIES INC produced more free cash flow last quarter ($61.0M vs $517.0K). Over the past eight quarters, TOOTSIE ROLL INDUSTRIES INC's revenue compounded faster (13.2% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.

CLB vs TR — Head-to-Head

Bigger by revenue
TR
TR
1.6× larger
TR
$196.3M
$121.8M
CLB
Growing faster (revenue YoY)
TR
TR
+2.9% gap
TR
1.5%
-1.4%
CLB
Higher net margin
TR
TR
10.5% more per $
TR
14.7%
4.2%
CLB
More free cash flow
TR
TR
$60.5M more FCF
TR
$61.0M
$517.0K
CLB
Faster 2-yr revenue CAGR
TR
TR
Annualised
TR
13.2%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
TR
TR
Revenue
$121.8M
$196.3M
Net Profit
$5.1M
$28.8M
Gross Margin
35.7%
Operating Margin
1.5%
17.0%
Net Margin
4.2%
14.7%
Revenue YoY
-1.4%
1.5%
Net Profit YoY
27.9%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
TR
TR
Q1 26
$121.8M
Q4 25
$138.3M
$196.3M
Q3 25
$134.5M
$232.7M
Q2 25
$130.2M
$155.1M
Q1 25
$123.6M
$148.5M
Q4 24
$129.2M
$193.4M
Q3 24
$134.4M
$225.9M
Q2 24
$130.6M
$150.7M
Net Profit
CLB
CLB
TR
TR
Q1 26
$5.1M
Q4 25
$4.9M
$28.8M
Q3 25
$14.2M
$35.7M
Q2 25
$10.6M
$17.5M
Q1 25
$-154.0K
$18.1M
Q4 24
$7.4M
$22.5M
Q3 24
$11.7M
$32.8M
Q2 24
$9.0M
$15.6M
Gross Margin
CLB
CLB
TR
TR
Q1 26
Q4 25
20.8%
35.7%
Q3 25
22.0%
34.1%
Q2 25
20.3%
36.4%
Q1 25
19.5%
35.3%
Q4 24
17.8%
39.1%
Q3 24
20.5%
34.1%
Q2 24
21.2%
33.5%
Operating Margin
CLB
CLB
TR
TR
Q1 26
1.5%
Q4 25
11.5%
17.0%
Q3 25
15.6%
13.9%
Q2 25
11.7%
7.8%
Q1 25
3.6%
15.5%
Q4 24
11.0%
20.0%
Q3 24
14.7%
15.6%
Q2 24
12.3%
10.2%
Net Margin
CLB
CLB
TR
TR
Q1 26
4.2%
Q4 25
3.6%
14.7%
Q3 25
10.6%
15.3%
Q2 25
8.2%
11.3%
Q1 25
-0.1%
12.2%
Q4 24
5.7%
11.6%
Q3 24
8.7%
14.5%
Q2 24
6.9%
10.4%
EPS (diluted)
CLB
CLB
TR
TR
Q1 26
$0.11
Q4 25
$0.11
Q3 25
$0.30
Q2 25
$0.22
Q1 25
$0.00
Q4 24
$0.15
Q3 24
$0.25
Q2 24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
TR
TR
Cash + ST InvestmentsLiquidity on hand
$22.8M
$176.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$941.0M
Total Assets
$587.7M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
TR
TR
Q1 26
$22.8M
Q4 25
$22.7M
$176.6M
Q3 25
$25.6M
$119.8M
Q2 25
$31.2M
$170.5M
Q1 25
$22.1M
$176.6M
Q4 24
$19.2M
$194.6M
Q3 24
$21.5M
$163.2M
Q2 24
$17.7M
$131.2M
Total Debt
CLB
CLB
TR
TR
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
TR
TR
Q1 26
$275.1M
Q4 25
$266.0M
$941.0M
Q3 25
$271.3M
$918.9M
Q2 25
$261.3M
$893.1M
Q1 25
$253.4M
$879.4M
Q4 24
$246.6M
$870.7M
Q3 24
$250.7M
$870.2M
Q2 24
$240.3M
$841.4M
Total Assets
CLB
CLB
TR
TR
Q1 26
$587.7M
Q4 25
$584.0M
$1.3B
Q3 25
$591.4M
$1.2B
Q2 25
$602.1M
$1.2B
Q1 25
$591.5M
$1.1B
Q4 24
$585.1M
$1.1B
Q3 24
$600.5M
$1.1B
Q2 24
$597.8M
$1.1B
Debt / Equity
CLB
CLB
TR
TR
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
TR
TR
Operating Cash FlowLast quarter
$4.0M
$73.3M
Free Cash FlowOCF − Capex
$517.0K
$61.0M
FCF MarginFCF / Revenue
0.4%
31.1%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
0.77×
2.55×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$96.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
TR
TR
Q1 26
$4.0M
Q4 25
$7.9M
$73.3M
Q3 25
$8.5M
$62.2M
Q2 25
$13.9M
$-8.5M
Q1 25
$6.7M
$3.6M
Q4 24
$20.6M
$68.8M
Q3 24
$13.1M
$61.3M
Q2 24
$17.1M
$-12.6M
Free Cash Flow
CLB
CLB
TR
TR
Q1 26
$517.0K
Q4 25
$5.0M
$61.0M
Q3 25
$6.5M
$50.7M
Q2 25
$10.4M
$-16.0M
Q1 25
$3.9M
$750.0K
Q4 24
$17.4M
$64.7M
Q3 24
$10.4M
$55.8M
Q2 24
$14.3M
$-16.6M
FCF Margin
CLB
CLB
TR
TR
Q1 26
0.4%
Q4 25
3.6%
31.1%
Q3 25
4.8%
21.8%
Q2 25
8.0%
-10.3%
Q1 25
3.1%
0.5%
Q4 24
13.4%
33.5%
Q3 24
7.7%
24.7%
Q2 24
10.9%
-11.0%
Capex Intensity
CLB
CLB
TR
TR
Q1 26
Q4 25
2.1%
6.3%
Q3 25
1.5%
5.0%
Q2 25
2.7%
4.8%
Q1 25
2.3%
1.9%
Q4 24
2.5%
2.1%
Q3 24
2.0%
2.4%
Q2 24
2.2%
2.6%
Cash Conversion
CLB
CLB
TR
TR
Q1 26
0.77×
Q4 25
1.61×
2.55×
Q3 25
0.60×
1.74×
Q2 25
1.31×
-0.49×
Q1 25
0.20×
Q4 24
2.78×
3.06×
Q3 24
1.12×
1.87×
Q2 24
1.90×
-0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

TR
TR

Products$194.3M99%
Rental And Royalty$1.9M1%

Related Comparisons